Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinct transcriptome architectures underlying lupus establishment and exacerbation
M Nakano, Mineto Ota, Yusuke Takeshima, et al.
Cell (2022) Vol. 185, Iss. 18, pp. 3375-3389.e21
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Systemic Lupus Erythematosus Pathogenesis: Interferon and Beyond
Simone Caielli, Zurong Wan, Virginia Pascual
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 533-560
Open Access | Times Cited: 108
Precision medicine in systemic lupus erythematosus
Serena Fasano, Alessandra Milone, Giovanni Francesco Nicoletti, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 6, pp. 331-342
Closed Access | Times Cited: 56
Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants
Carola G. Vinuesa, Nan Shen, Thuvaraka Ware
Nature Reviews Nephrology (2023) Vol. 19, Iss. 9, pp. 558-572
Closed Access | Times Cited: 38
Age-associated CD4 + T cells with B cell–promoting functions are regulated by ZEB2 in autoimmunity
M. Goto, H. Takahashi, Ryochi Yoshida, et al.
Science Immunology (2024) Vol. 9, Iss. 93
Closed Access | Times Cited: 11
Neoself-antigens are the primary target for autoreactive T cells in human lupus
Shunsuke Mori, Masako Kohyama, Yoshiaki Yasumizu, et al.
Cell (2024)
Closed Access | Times Cited: 10
Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics
Miro E. Raeber, Dominic Caspar, Yves Zurbuchen, et al.
Immunity (2024) Vol. 57, Iss. 9, pp. 2232-2250.e10
Open Access | Times Cited: 9
Effect of Epstein-Barr Virus infection on gene regulation in immune cells of patients with Immune-Mediated Diseases
Y. Akutsu, Mineto Ota, Takahiro Itamiya, et al.
Journal of Autoimmunity (2025) Vol. 150, pp. 103355-103355
Closed Access | Times Cited: 1
Advances in Targeted Therapy for Systemic Lupus Erythematosus: Current Treatments and Novel Approaches
Kaoru Saegusa, Yumi Tsuchida, Toshihiko Komai, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 929-929
Open Access | Times Cited: 1
Multimodal repertoire analysis unveils B cell biology in immune-mediated diseases
Mineto Ota, M Nakano, Yasuo Nagafuchi, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 11, pp. 1455-1463
Open Access | Times Cited: 20
Systemic lupus erythematosus genetics: insights into pathogenesis and implications for therapy
Yogita Ghodke‐Puranik, Mikhail Olferiev, Mary K. Crow
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 10, pp. 635-648
Closed Access | Times Cited: 8
Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis
Alice Horisberger, Alec Griffith, Joshua Keegan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Accelerated plasma-cell differentiation in Bach2-deficient mouse B cells is caused by altered IRF4 functions
Kyoko Ochiai, Hiroki Shima, Toru Tamahara, et al.
The EMBO Journal (2024) Vol. 43, Iss. 10, pp. 1947-1964
Open Access | Times Cited: 6
Low‐density granulocytes in systemic autoimmunity and autoinflammation
Carmelo Carmona‐Rivera, Mariana J. Kaplan
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 313-325
Open Access | Times Cited: 25
Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE
Eduardo Gómez-Bañuelos, Daniel Goldman, Victoria Soledad Andrade, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101569-101569
Open Access | Times Cited: 5
ITGA5+synovial fibroblasts orchestrate proinflammatory niche formation by remodelling the local immune microenvironment in rheumatoid arthritis
Linli Zheng, Minghui Gu, Xiang Li, et al.
Annals of the Rheumatic Diseases (2024) Vol. 84, Iss. 2, pp. 232-252
Closed Access | Times Cited: 5
Memory B cells and their transcriptomic profiles associated with belimumab resistance in systemic lupus erythematosus in the maintenance phase
Takeshi Iwasaki, Hajime Yoshifuji, Koji Kitagori, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Body weight in systemic lupus erythematosus is associated with disease activity and the adaptive immune system, independent of type I IFN
Hiroyuki Teruya, Hirofumi Shoda, Takahiro Itamiya, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Jieduquyuziyin Prescription Suppresses the Activation of the Extrafollicular Effector B Cell by Regulating Integrin Αv Signaling in Systemic Lupus Erythematosus
Liying Chen, Ting Fang, Xingxing Yao, et al.
(2025)
Closed Access
Association of peripheral CD8+T cell activation with disease activity and treatment resistance in systemic lupus erythematosus
Yuya Fujita, Shingo Nakayamada, Satoshi Kubo, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e005122-e005122
Open Access
Treatment strategy for systemic lupus erythematosus using belimumab as indicated by multi‐omics analysis
Keishi Fujio, Toshiyuki Ushijima, Tatsuki Abe, et al.
Rheumatology & autoimmunity (2025)
Open Access
Integration of transcriptome and immunophenotyping data highlights differences in the pathogenetic kinetics of B cells across immune-mediated disease
Shinji Izuka, Toshihiko Komai, Takahiro Itamiya, et al.
RMD Open (2025) Vol. 11, Iss. 2, pp. e005310-e005310
Open Access
Precision Reimagined: CRISPR and Multiomics Transform Systemic Lupus Erythematosus Diagnosis and Therapy
Zhuo Chen, Elaheh Pilehvar, Haleh Sadeghi, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 4
Closed Access
Jieduquyuziyin prescription suppresses the activation of the extrafollicular effector B cell by regulating integrin αV signaling in systemic lupus erythematosus
Liying Chen, Ting Fang, Xingxing Yao, et al.
Journal of Ethnopharmacology (2025), pp. 119914-119914
Closed Access
A cellular overview of immunometabolism in systemic lupus erythematosus
Antonios Psarras, Alexander J. Clarke
Oxford Open Immunology (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 10
2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus
Huiqi Yin, Liming Li, Xiwei Feng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top